NovoCure Limited - Ordinary Shares (NQ:NVCR)

14.94 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer

September 09, 2021

From Novocure

Via Business Wire

Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

September 02, 2021

From Novocure

Via Business Wire

Novocure Appoints Bill Burke as Chief Human Resources Officer

September 01, 2021

From Novocure

Via Business Wire

Friday the Thirteenth ↗

August 13, 2021

The stock week in points eastward was mixed. The USA markets face a bear correction.

Via Talk Markets

NovoCure: Q2 Earnings Insights ↗

July 29, 2021

Shares of NovoCure (NASDAQ:NVCR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were down 800.00% over the past year to ($0...

Via Benzinga

Earnings Scheduled For July 29, 2021 ↗

July 29, 2021

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...

Via Benzinga

What's Next for Novocure? ↗

August 13, 2021

The company has several key data readouts on the way.

Via The Motley Fool

Delta Outbreak ↗

August 04, 2021

The US market was droopy because of poor private sector jobless numbers.

Via Talk Markets

Cramer Advises Viewers On Palantir, SoFi And More ↗

August 04, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer....

Via Benzinga

Know When To Hold 'Em, Know When To Fold 'Em ... ↗

August 02, 2021

A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks.

Via Talk Markets

Here's Why Novocure Dipped 19% This Week ↗

July 30, 2021

Uptake of the company's revolutionary disease-controlling device isn't progressing as quickly as expected.

Via The Motley Fool

70 Biggest Movers From Yesterday ↗

July 30, 2021

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...

Via Benzinga

News Overload ↗

July 29, 2021

Today US markets managed a rally despite misses in both the growth and employment data.

Via Talk Markets

Why Novocure Tanked on Thursday ↗

July 29, 2021

Investors are seeing red in the company's latest earnings report.

Via The Motley Fool

NovoCure (NVCR) Q2 2021 Earnings Call Transcript ↗

July 29, 2021

NVCR earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Novocure Stock Dips As Q2 Earnings Trail Estimates; Higher Costs Hit Bottom Line ↗

July 29, 2021

Novocure Ltd (NASDAQ: NVCR) posted a net loss of $14.6 million in Q2, compared to a net income of $1.7 million a year ago. EPS came in at $(0.14), missing the consensus...

Via Benzinga

Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update

July 29, 2021

From Novocure

Via Business Wire

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Full News Day ↗

July 28, 2021

The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.

Via Talk Markets

Topics Energy

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Containment Plan ↗

July 23, 2021

Today the US decided to cut China risks.

Via Talk Markets

Joblessness Surprise ↗

July 22, 2021

Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.

Via Talk Markets

“Claw-Back” day ↗

July 20, 2021

The rally was just as irrational as the selloff.

Via Talk Markets

Weak Week ↗

July 16, 2021

Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.

Via Talk Markets

Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

July 15, 2021

From Novocure

Via Business Wire

Yellow Card ↗

July 12, 2021

The price of oil fell about 1% today.

Via Talk Markets

Novocure to Report Second Quarter 2021 Financial Results

July 08, 2021

From Novocure

Via Business Wire

Fireworks Display ↗

July 05, 2021

The oil price rose to 76.81/bbl after the OPEC attempt to have a meeting to agree to boost production (and cut prices) was blocked.

Via Talk Markets

People Needed ↗

July 02, 2021

If qualified people are not looking for work, they will have to be lured to do so with higher wages.

Via Talk Markets

Stock Market Rally: S&P 500, Nasdaq Hit Highs; Facebook, Tesla, Nio, Intellia, Didi IPO, OPEC+ In Focus ↗

July 02, 2021

The S&P 500 and Nasdaq hit record highs last week. Facebook hit a $1 trillion market cap. Tesla deliveries jumped.

Via Investor's Business Daily

Topics Initial Public Offering Stocks

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.